The Foundation for Children with Atypical HUS

Our insurance carrier recently approved the use of Soliris in conjunction with a kidney transplant for Alyssa.  She has 2 defects in her I chromosome and a thrombomodulin alteration, any one of whcih could possibly have led to A-HUS--or possibly it took all three as well as an environmental assault such as a flu or birth control pills to push it over the edge to become active at the age of 21.  The Doctors don't really know but they do beleive that there is a 90% liklihood of recurrence of the HUS once she has a transplant, if she does not receive the Soliris.  It is our understanding that she will be the first in the world to have a transplant with the simultaneous use of this drug.  She has been on dialysis for over a year now, having first been diagnosed with A-HUS in January 1009.  We are hopeful that maybe her own kidney function might return as she has never been given Soliris before and maybe her kidneys could repair themselves if the hemolysis is completely stopped.  Unfortunately the Doctors are not hopeful that there is much chance for that but I never give up hope.   The plan is to have her go on pherisis and soliris for a week or two before the transplant. The actual transplant would take place in Iowa where they have some experience with A-HUS.   Alyssa is very fortunate to have a live donor who has volunteered and so far has been compatible.  We live in Rochester, New York so the logistics of all of this is going to be difficult but of course we will do whatever it takes.  Alyssa has been through so much and has not felt well in such a long time.  She does the peritoneal dialysis  and certainly likes that much better than the hemodialysis.  Blood pressures have been eiher way too high or more recently too low.  Since there is always the fear of infection, we are planning to move as quickly as possible now that we have the approval.  It looks like we will likely go to Iowa at the end of June or early July.   If anyone has any information or suggestions that could help us, please let us know.  I know there are several children using Soliris and I am grateful for any input. 

Views: 188

Reply to This

Replies to This Discussion

Hi Christie....We were very fortunate to have our insurance company approve Soliris and we believe it was due in large part to the efforts of Alyssa's hematologist who wrote an impassioned letter about Alyssa to the carrier and requested a meeting with the head doctor of the carrier.  Her hematologist also has an excellent reputation and a good relationship with the carrier's doctors.   They approved it very quickly.  The approval has to be reviewed every six months but our doctor is optimistic that it will continue to be approved if he can demonstrate it is continuing to work.  She receives 900 mg every two weeks now.  She was receiving 1200 but had some discomfort in terms of facial  flushing and muscle pain (nothing unbearable) so the dose was reduced and she is doing better as far as side effects go.  It will be a trial and error type approach as no one knows the proper dose since this is a new treatment for a-HUS.  We feel especially fortunate that the company (BC/BS Excellus) approved the drug for Alyssa as it is so expensive (your figures are right!) and Alyssa has a close friend, Jill (also on this site) who cannot get approval after several tries.  We are still hopeful something will come through for her ...this is her year for a successful transplant.  Maybe the more patients who have success with a transplant on Soliris will also help convince the carriers to approve as it will be less  experimental.  We wish you all the best in your efforts--if there is anything we can get for you that might help--just let us know.
Ethan Ardoin said:

Hello Deborah,

Can you tell me the steps you took that convinced your insurance carrier to approve the use of Soliris in conjunction with a kidney transplant? Our sons doctor is very interested in moving in this direction. He has indicated that without insurance the cost of the medicine would be extreme ($30,000/month)???  

thanks,

Christie

Reply to Discussion

RSS

WELCOME - Friends, Family Members, Patients, and Researchers - JOIN US!

The Foundation for Children with Atypical HUS encourages patients and investigators to share information and explore options/resources as we work together to gain insight into this rare complement disorder. By increasing contact opportunities with researchers and medical personnel interested in helping the aHUS community, our stories foster a better understanding of atypical hemolytic uremic syndrome.

Sharing information, inspiration and support for one another, we seek to gather together people and knowledge as we strive to improve the lives of patients and families dealing with a diagnosis of aHUS.


NEW DIAGNOSIS OF aHUS?
Be proactive! Get the medical basics of aHUS, what lab values to monitor, and areas of concern...check out the "aHUS Bootcamp" and "About aHUS" tabs at the top of this page!
If your doctor has never treated a case of aHUS, please print out our 'Doc to Doc Registry' and ask him/her to contact a physician versed in the complexities of aHUS and new options for 2011 genetic testing and treatment.

************************

NOTE: Our 'Send a Message" function on each Member's page allows for private discussion of personal content. As with any social network, be cautious about giving personal contact information (home email info, phone number) until you have an established relationship with another person, organization, or associated website.

 

Did you know...

CFH (Serum Complement Factor H) is a regulatory protein. The secreted protein product of CFH consists of 20 repetitive units named "short consensus repeats" or SCRs (each approximately 60 amino acids). In patients with aHUS the last 5 "pearls" in the twenty pearl strand protein, SCR16 - SCR20, should bind to protect cells but do not- they are defective in one or more of the last 5 SCR locations. If they cannot bind or stick to the kidney to protect that tissue, the platelets clump into clots that affect the glomeruli of the kidney -potentially causing acute renal failure.
  
• • • • • • • • • • • •
  
It is estimated that there are about 300 cases of aHUS in the U.S., and it is most common with young children. The condition is life threatening and either can be chronic or can recur at intervals.
  
more factoids...

Help us fight the battle

Your tax-deductible purchase of one or more bracelets will directly fund research to help end the tragedy and heartbreak that aHUS families live with every day. Each bracelet has an appraised value of $825, but your purchase price is only $295.

  

  
Or you can donate a specific dollar amount-every dollar will help the Foundation for Children with atypical HUS atypicalHUS.50megs.com


Donations may be made via credit card or Paypal. If you prefer, checks made payable to The Foundation for Children with Atypical HUS may be mailed to:
Atypical aHUS Foundation
19 Olde Colony Lane
Cape Elizabeth, ME 04107
For pearl bracelet orders, please allow extra time for processing checks.



Badge

Loading…

© 2012   Created by ALPHA MARKETING.   Powered by .

Badges  |  Report an Issue  |  Terms of Service